India Globalization Capital (IGC) 10-K 14 Jun 19 2019 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Mar. 31, 2019	Jun. 11, 2019	Sep. 28, 2018
Document and Entity Information [Abstract]
Entity Registrant Name	India Globalization Capital, Inc.
Document Type	10-K
Current Fiscal Year End Date	--03-31
Entity Common Stock, Shares Outstanding		39,511,407
Entity Public Float			$ 193,000,000
Amendment Flag	false
Entity Central Index Key	0001326205
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Accelerated Filer
Entity Well-known Seasoned Issuer	No
Document Period End Date	Mar. 31, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	FY
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Ex Transition Period	false

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2019	Mar. 31, 2018
Current assets:
Cash and cash equivalents	$ 25,610	$ 1,658
Accounts receivable, net of allowances of 6 and 11	84	558
Inventory	248	486
Investment held for sale	0	148
Deposits and advances	781	355
Total current assets	26,723	3,205
Intangible assets, net	184	128
Property, plant and equipment, net	5,886	6,237
Investments in unlisted securities	794	799
Claims and advances	878	484
Total long-term assets	7,742	7,648
Total assets	34,465	10,853
Current liabilities:
Accounts payable	319	258
Accrued liabilities and others	509	288
Short-term loan	50	0
Notes payable	0	1,800
Total current liabilities	878	2,346
Loan	0	427
Other liabilities	15	15
Total non-current liabilities	15	442
Total liabilities	893	2,788
Stockholders' equity:
Common stock and additional paid-in capital, $0.0001 par value: 150,000,000 shares authorized; 39,501,407 and 30,764,192 shares issued and outstanding as on March 31, 2019 and March 31, 2018 respectively.	94,043	63,917
Accumulated other comprehensive loss	(2,419)	(2,057)
Accumulated deficit	(58,052)	(53,795)
Total stockholders' equity	33,572	8,065
Total liabilities and stockholders' equity	$ 34,465	$ 10,853

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parentheticals) - $ / shares	Mar. 31, 2019	Mar. 31, 2018
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	150,000,000	150,000,000
Common stock, shares issued	39,501,407	30,764,192
Common stock, shares outstanding	39,501,407	30,764,192

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Revenues	$ 5,116	$ 2,193
Cost of revenues	(4,984)	(2,111)
Gross profit	132	82
General and administrative expenses	(3,519)	(1,734)
Research and development expenses	(1,256)	(137)
Operating loss	(4,643)	(1,789)
Other income – net	548	3
Loss before income taxes	(4,095)	(1,786)
Income taxes expense	(2)	0
Net loss attributable to common stockholders	(4,097)	(1,786)
Foreign currency translation adjustments	(362)	(9)
Comprehensive loss	$ (4,459)	$ (1,795)
Loss per share attributable to common stockholders:
Basic & diluted (in Dollars per share)	$ (0.13)	$ (0.06)
Weighted-average number of shares used in computing loss per share amounts: (in Shares)	35,393	27,937

CONSOLIDATED STATEMENT OF STOCK

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Common Stock [Member]Private Placement [Member]	Common Stock [Member]	Common Stock Including Additional Paid in Capital [Member]Private Placement [Member]	Common Stock Including Additional Paid in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Noncontrolling Interest [Member]	Private Placement [Member]	Total
Balances at Mar. 31, 2017				$ 61,416	$ (52,009)	$ (2,048)	$ (9)		$ 7,350
Balances (in Shares) at Mar. 31, 2017		28,273,000
Common stock issued through offering				3,489					3,489
Common stock issued through offering (in Shares)		4,852,000
Bricoleur Note penalty shares				191					191
Bricoleur Note penalty shares (in Shares)		360,000
Share based compensation & options to advisors and employees				659					659
Share based compensation & options to advisors and employees (in Shares)		1,179,000
Cancellation of shares				(1,880)					(1,880)
Cancellation of shares (in Shares)		(4,000,000)
Payment for acquisition of patent				42					42
Payment for acquisition of patent (in Shares)		100,000
Loss on foreign currency translation						(9)			(9)
Non-controlling interest adjustment							$ 9		9
Net income loss					(1,786)				(1,786)
Balances at Mar. 31, 2018				63,917	(53,795)	(2,057)			$ 8,065
Balances (in Shares) at Mar. 31, 2018		30,764,000							30,764,192
Common stock issued through offering			$ 950	28,508				$ 950	$ 28,508
Common stock issued through offering (in Shares)	870,000	5,899,000							5,898,656
Adoption of ASU 2018-07				31	(31)				$ 30
Bricoleur Note penalty shares				18					18
Bricoleur Note penalty shares (in Shares)		30,000
Share based compensation & options to advisors and employees				638					638
Share based compensation & options to advisors and employees (in Shares)		2,019,000
Cancellation of shares				(19)	(129)				(148)
Cancellation of shares (in Shares)		(80,000)
Loss on foreign currency translation						(362)			(362)
Net income loss					(4,097)				(4,097)
Balances at Mar. 31, 2019				$ (94,043)	$ (58,052)	$ (2,419)			$ 33,572
Balances (in Shares) at Mar. 31, 2019		39,502,000							39,501,407

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash flows from operating activities:
Net loss	$ (4,097)	$ (1,786)
Adjustment to reconcile net loss to net cash:
Depreciation	59	19
Other operating expenses, net	0	14
Non-cash Interest	18	0
Gain on settlement of note payable, net	(300)	0
Share based compensation and other expenses	610	576
Changes in:
Accounts receivable	474	(34)
Inventory	239	(424)
Deposits and advances	(422)	65
Claims and advances	(193)	(361)
Trade payables and accrued liabilities	282	0
Net cash used in operating activities	(3,330)	(1,931)
Cash flow from investing activities:
Purchase of property, plant and equipment	(15)	(136)
Deconsolidation adjustment	0	(456)
Loan given	(200)	0
Acquisition and filing cost of patents and rights	(45)	(65)
Net cash used by investing activities	(260)	(657)
Cash flows from financing activities:
Issuance of equity stock through public offering (net of expenses)	28,508	3,489
Issuance of equity stock through private placement (net of expenses)	950	0
Proceed from option exercised	18	0
Non-cash interest/penalty expenses	0	191
Repayment of loan	(1,878)	35
Net cash provided by financing activities	27,598	3,715
Effects of exchange rate changes on cash and cash equivalents	(56)	(7)
Net increase in cash and cash equivalents	23,952	1,120
Cash and cash equivalent at the beginning of the period	1,658	538
Cash and cash equivalent at the end of the period	25,610	1,658
Supplementary information:
Cash paid for interest	14	31
Non-cash items:
Common stock issued including ESOP, consultancy and patent acquisition	610	701
Common stock issued as penalty on notes payable	$ 18	$ 191

NOTE 1 - NATURE OF OPERATIONS A

NOTE 1 - NATURE OF OPERATIONS AND MANAGEMENT’S PLANS	12 Months Ended
	Mar. 31, 2019
Disclosure Text Block [Abstract]
Nature of Operations [Text Block]	NOTE 1 – NATURE OF OPERATIONS AND MANAGEMENT’S PLANS IGC has two lines of business: 1) infrastructure and 2) plant and cannabinoid-based products and therapies. The Company’s infrastructure business, managed from India, involves: (a) the rental of heavy construction equipment; (b) execution of construction contracts; and (c) the purchase and resale of physical commodities used in infrastructure, (collectively, the “Infrastructure Business”). Our second line of business (collectively, the “Plant and Cannabinoid Business”), stems from plant material and cannabinoids produced by the cannabis plant. It involves several brands that the Company develops and expects to commercialize as alternative plant and cannabinoid-based therapies. The Company’s flagship branded, patent pending, product is Hyalolex™. In addition, the Company, under the brand name Holi Hemp™, sells hemp crude extract, hemp isolate, and hemp distillate. The Company’s principal office in the U.S. is in Potomac, Maryland, and the Company has a facility in Washington State and offices in Delhi and Kerala, India. The Company’s fiscal is the 52 or 53-week period that ends on the last day of March. The Company’s Fiscal 2019 consists of the 52 weeks ended on March 31, 2019. Unless otherwise stated, references to particular years, quarters, months and periods refer to the Company’s fiscal years ended in March and the associated quarters, months and periods of those fiscal years. Business updates In Fiscal 2019, we incorporated three wholly owned U.S. based subsidiaries: IGC Pharma LLC, that will own our intellectual property, conduct R&D, and conduct medical trials; IGCare LLC, that will sell certain cannabinoid products; and Holi Hemp LLC, that will wholesale and retail certain products such as hemp crude extract, hemp distillate, and hemp isolate, among others. In Fiscal 2018, the Company incorporated one indirectly wholly-owned subsidiary in Hongkong – IGC Enterprises Limited. On March 23, 2019, we sold our Malaysian subsidiary Cabaran Ultima and received back 80,000 shares of IGC common stock from the buyer of Cabaran. There was no operating activity or gain and loss in the subsidiary in Fiscal 2019.

NOTE 2 - SIGNIFICANT ACCOUNTING

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Mar. 31, 2019
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES a) Principles of consolidation The consolidated financial statements include the accounts of the Company and all of its subsidiaries. Intercompany accounts and transactions have been eliminated. In the opinion of the Company’s management, the consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. Transactions between the Company and its subsidiaries are eliminated in the consolidated financial statements. b ) Reclassifications Certain prior period amounts in the consolidated financial statements and accompanying notes have been reclassified to conform to the current period’s presentation. Certain aged receivables and certain deposits and advances in the amount of approximately $644 thousand have been reclassified to non-current assets from current assets. In Fiscal 2019, a Note Payable in the amount of $1.8 Million has been paid off. Please see “Note 10 – Loans and Other Liabilities”, in our Notes to Consolidated Financial Statements contained herein for more information. c ) Use of estimates The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Management believes that the estimates and assumptions used in the preparation of the consolidated financial statements are prudent and reasonable. Significant estimates and assumptions are generally used for, but not limited to: allowance for uncollectible accounts receivable; future obligations under employee benefit plans; the useful lives of property, plant, equipment; intangible assets; valuations; impairment of goodwill and investments; recoverability of advances; the valuation of options granted and warrants issued; and income tax and deferred tax valuation allowances, if any. Actual results could differ from those estimates. Appropriate changes in estimates are made as management becomes aware of changes in circumstances surrounding the estimates. Critical accounting estimates could change from period to period and could have a material impact on IGC’s results, operations, financial position and cash flows. Changes in estimates are reflected in the financial statements in the period in which changes are made and, if material, their effects are disclosed in the notes to the consolidated financial statements. d ) Revenue recognition The Company recognizes revenue under ASC 606, Revenue from Contracts with Customers ASC 606 prescribes a 5-step process to achieve its core principle. The Company recognizes revenue from trading, rental, or product sales as follows: I. Identify the contract with the customer. II. Identify the contractual performance obligations. III. Determine the amount of consideration/price for the transaction. IV. Allocate the determined amount of consideration/price to the contractual obligations. V. Recognize revenue when or as the performing party satisfies performance obligations. The consideration/price for the transaction (performance obligation(s)) is determined as per the agreement or invoice (contract) for the services and products in the Infrastructure Business and Plant and Cannabinoid Business. Revenue in the Infrastructure Business is recognized for the renting and contracting business once the obligation as per the agreement has been completed by the company. The revenue from the purchase and resale of physical infrastructure commodities is recognized once the bill of lading along with the invoice have been transferred to the customer. In the Plant and Cannabinoid Business, the revenue from the cannabinoid-based products is recognized in Holi Hemp once goods have been sold to the customer and the performance obligation has been completed. While in IGCare, we license our products to processors. The revenue from the cannabinoid-based products and therapies is recognized once goods have been sold to the customer by the outlets and the performance obligation is completed as per the agreement. Net sales disaggregated by significant products and services for Fiscal 2019 and Fiscal 2018 were as follows (in thousands): Year Ended March 31, 2019 ($) 2018 ($) Infrastructure Business Rental income (1) 30 45 Construction contracts (2) - 62 Purchase and resale of physical commodities (3) 5,061 2,086 Plant and Cannabinoid Business Cannabinoid products and therapies (4) 25 - Total 5,116 2,193 (1) Rental income consists of income from rental of heavy construction equipment like bulldozers, excavators, rollers and pavers, among others. (2) Relates to the income from execution of construction contracts. (3) Relates to the income from purchase and resale of physical commodities used in infrastructure, like steel, marble and tiles. (4) Relates to the revenue from plant and cannabinoid-based products and therapies such as hemp crude extract, hemp isolate, and hemp distillate. There was no revenue from Hyalolex™ During Fiscal 2019 and 2018, the Company had approximately $5,091 thousand and $2,193 thousand of revenue respectively in Infrastructure Business. During Fiscal 2019, the Company reported $25 thousand in revenue from the Plant and Cannabinoid Business. e ) Basic and diluted loss per share Basic loss per common share is computed by dividing net loss available to common stockholders by the weighted average number of common stock outstanding. Diluted loss per common share is computed similar to basic loss per common share except that the denominator is increased to include the number of additional shares of common stock that would have been outstanding if the potential common stock had been issued and if the additional shares of common stock were dilutive. The weighted average number of shares outstanding for Fiscal 2019 and Fiscal 2018 used for the computation of basic EPS is 35,393,407 and 27,937,287 shares, respectively. Potential common stock consists of the incremental common stock issuable upon the exercise of common stock warrants (using the if-converted method). The computation of basic loss per share for the year ended March 31, 2019 excludes potentially dilutive securities of 3.3 million shares underlying common stock, warrants and options, because their inclusion would be antidilutive. As a result, the computations of net loss per share for each period presented is the same for both basic and fully diluted. f ) Income taxes The Company accounts for income taxes under the asset and liability method, in accordance with ASC 740, Income Taxes, which requires an entity to recognize deferred tax liabilities and assets. Deferred tax assets and liabilities are recognized for the future tax consequence attributable to the differences between the financial statement carrying amounts of existing assets and liabilities and their tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the enacted tax rate expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. A valuation allowance is established and recorded when management determines that some or all of the deferred tax assets are not likely to be realized and therefore, it is necessary to reduce deferred tax assets to the amount expected to be realized. In evaluating a tax position for recognition, management evaluates whether it is more-likely-than-not that a position will be sustained upon examination, including resolution of related appeals or litigation processes, based on technical merits of the position. If the tax position meets the more-likely-than-not recognition threshold, the tax position is measured and recognized in the Company’s financial statements as the largest amount of tax benefit that, in management’s judgment, is greater than 50% likely of being realized upon settlement. As of March 31, 2019, and 2018, there was no significant liability for income tax associated with unrecognized tax benefits. g) Accounts receivable Accounts receivable represents amounts owed from customers in the Infrastructure Business. The Company estimates reserves for bad debts based on general aging, experience and past-due status of the accounts. The allowance for doubtful accounts is determined by evaluating the relative credit worthiness of each client, historical collections experience and other information, including the aging of the receivables. h ) Cash and cash equivalents For financial statement purposes, the Company considers all highly liquid debt instruments with maturity of three months or less, to be cash equivalents. The Company maintains its cash in bank accounts in the U.S., India, and Hong Kong, which at times may exceed applicable insurance limits. The cash in foreign subsidiaries as on March 31, 2019 and 2018, was approximately $284 thousand and $30 thousand, respectively. i ) Short-term and long-term investments Our policy for short-term and long-term investments is to establish a high-quality portfolio that preserves principal, meets liquidity needs, avoids inappropriate concentrations and delivers an appropriate yield in relationship to our investment guidelines and market conditions. Short-term and long-term investments consist of corporate, various government agency and municipal debt securities, as well as certificates of deposit that have maturity dates that are greater than 90 days. Certificates of deposit and commercial paper are carried at cost which approximates fair value. We classify our marketable securities as available-for-sale in accordance with FASB ASC Topic 320, “Investments — Debt and Equity Securities”. Available-for-sale securities are carried at fair value with unrealized gains and losses reported in stockholders’ equity, net of related tax effects. Other Investments are initially measured at cost, which is the fair value of the consideration given for them, including transaction costs. The Company’s equity in the earnings/(losses) of affiliates is included in the statement of income and the Company’s share of net assets of affiliates is included in the balance sheet. Where the Company’s ownership interest is in excess of 25% and the Company enjoys significant interest, the Company has accounted for the investment based on the equity method. In Fiscal 2019 and 2018, the Company concluded that it does not have significant influence over Midtown Partner LLC (MTP). Therefore, the Company did not recognize any changes in MTP’s earnings/(losses). The investment is valued at the same value as in Fiscal 2017. j ) Property, plant and equipment (PP&E) Property and equipment are recorded at cost net of accumulated depreciation and depreciated over their estimated useful lives using the straight-line method. Upon retirement or disposition, cost and related accumulated depreciation of the property and equipment are de-recognized and any gain or loss is reflected in the results of operation. Cost of additions and substantial improvements to property and equipment are capitalized. The cost of maintenance and repairs of the property and equipment are charged to operating expenses as incurred. k ) Fair value of financial instruments FASB ASC No. 820, “Fair Value Measurement” defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. It also establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: Level 1: Observable inputs such as quoted prices in active markets; Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. The carrying amounts of the Company’s financial instrument includes cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities, approximate their fair values due to the nature of the items. As of March 31, 2019, the Company’s investments are Level 3 instruments. Financial instruments are classified as current if they are expected to be liquidated within the next twelve months. For further information refer Note 7 – Investments in Unlisted Securities. l ) Concentration of credit risk and significant customers Financial instruments, which potentially expose the Company to concentrations of credit risk, are primarily comprised of cash and cash equivalents, investments, accounts receivable and unbilled accounts receivable, if any. The Company places its cash, investments in highly rated financial institutions. The Company adheres to a formal investment policy with the primary objective of preservation of principal, which contains credit rating minimums and diversification requirements. Management believes its credit policies reflect normal industry terms and business risk. The Company does not anticipate non-performance by the counterparties and, accordingly, does not require collateral. During Fiscal 2019, sales were spread across customers in Asia and U.S. and the credit concentration risk is low. m ) Stock – Based Compensation The Company accounts for stock-based compensation to employees and non-employees in conformity with the provisions of ASC 718, Stock-Based Compensation n ) Commitments and contingencies Liabilities for loss contingencies arising from claims, assessments, litigations, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment and/or remediation can be reasonably estimated. We record associated legal fees as incurred. Information regarding our commitments and contingencies is incorporated by reference in Note 11 of this annual report on Form 10-K. o ) Impairment of long – lived assets The Company reviews its long-lived assets, with finite lives, for impairment whenever events or changes in business circumstances indicate that the carrying amount of assets may not be fully recoverable. Such circumstances include, though are not limited to, significant or sustained declines in revenues or earnings, future anticipated cash flows, business plans and material adverse changes in the economic climate, such as changes in operating environment, competitive information and impact of changes in government policies. For assets that the Company intends to hold for use, if the total of the expected future undiscounted cash flows produced by the assets or subsidiary company is less than the carrying amount of the assets, a loss is recognized for the difference between the fair value and carrying value of the assets. For assets the Company intends to dispose of by sale, a loss is recognized for the amount by which the estimated fair value less cost to sell is less than the carrying value of the assets. Fair value is determined based on quoted market prices, if available, or other valuation techniques including discounted future net cash flows. Unlike goodwill, long-lived assets are assessed for impairment only where there are any specific indicators for impairment. p) Inventor y Inventory, consisting of products available for sale, are primarily accounted for using the first-in first-out method, and are valued at the lower of cost or market, the term market means current replacement cost, provided that it meets both the following conditions: a) market shall not exceed the net realizable value, and b) market shall not be less than net realizable value reduced by an allowance for an approximately normal profit margin. This valuation requires us to make judgments, based on currently available information, about the likely method of disposition, such as through sales to individual customers, returns to product vendors, or liquidations, and expected recoverable values of each disposition category. These assumptions about future disposition of inventory are inherently uncertain and changes in our estimates and assumptions may cause us to realize material write-downs in the future. q ) Cyber s ecurity We have a cybersecurity policy in place and tighter cybersecurity measures to safeguard against hackers. In Fiscal 2019, there were no impactful breaches in cybersecurity. r ) Hedging The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risks. The Company evaluates its financial instruments, including equity-linked financial instruments, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. s ) Research and Development Expenses During Fiscal 2019 and Fiscal 2018, the Company recorded research and development expense of approximately $1,256 thousand and $137 thousand respectively. All research and development costs are expensed in the period in which they are incurred. t ) Recently issued and adopted accounting pronouncements Changes to U.S. GAAP are established by the Financial Accounting Standards Board (FASB) in the form of accounting standards updates (ASUs) to the FASB’s Accounting Standards Codification. The Company considers the applicability and impact of all ASUs. Newly issued ASUs not listed below are expected to have no impact on the Company’s consolidated financial position and results of operations, because either the ASU is not applicable, or the impact is expected to be immaterial. Adopted Business Combination: Reporting Comprehensive Income: Stock-Based Compensation Not yet adopted Credit Losses: Leases: D isclosures:

NOTE 3 - INVENTORY

NOTE 3 - INVENTORY	12 Months Ended
	Mar. 31, 2019
Inventory Disclosure [Abstract]
Inventory Disclosure [Text Block]	NOTE 3 – INVENTOR Y (in thousands) As of March 31, 2019 ($) 2018 ($) WIP 248 486 Total 248 486 Fiscal 2019 inventory consists of hemp crude oil and hemp distillate, whereas Fiscal 2018 inventory consisted of Hyalolex™ and its components. The 2018 Farm Bill that legalized hemp created an opportunity to reformulate some of our formulations to comply with the 2018 Farm Bill by keeping THC below 0.3% by dry weight. Management decided to repurpose the formulation of Hyalolex™ and its components for other products as well as for reformulating Hyalolex™ and therefore expensed the inventory as R&D in Fiscal 2019.

NOTE 4 - DEPOSITS AND ADVANCES

NOTE 4 - DEPOSITS AND ADVANCES	12 Months Ended
	Mar. 31, 2019
Deposits and Advances [Abstract]
Deposits and Advances [Text Block]	NOTE 4 – DEPOSITS AND ADVANCES (in thousands) As of March 31, 201 9 ($) 201 8 ($) Advance to suppliers and consultants 720 300 Statutory advances 43 44 Other current assets 18 11 Total 781 355

NOTE 5 - INTANGIBLE ASSETS

NOTE 5 - INTANGIBLE ASSETS	12 Months Ended
	Mar. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets Disclosure [Text Block]	NOTE 5 – INTANGIBLE ASSETS (in thousands) As of March 31, 2019 ($) 2018 ($) Patent & other intangible assets at the beginning of the period 128 - Patent acquisition and filing expenses for 12 months (Net) 56 128 Total 184 128 (i) The value of intangibles include the acquisition of patent rights, data, and the filing of patents. The amortization of acquired patent rights is 13 years from Fiscal 2020. There was no amortization of intangible assets during Fiscal 2019 and Fiscal 2018. On November 6, 2018, the Company received notification from the USPTO of the patent issuance (#10,117,891) for its cannabinoid method and composition for the treatment of neuropathic pain in patients with Psoriatic Arthritis, Fibromyalgia, Scleroderma and other conditions. The formulation consists of micro-doses of the cannabinoids THC and CBD as well as other ingredients. The formulation for relieving pain is expected to be marketed under the brand Natrinol™. On October 12, 2018 the Company filed a provisional patent with the USPTO for a CBD-infused energy drink titled “Method and Composition for Relieving Fatigue and Restoring Energy”. On September 25, 2018, IGC executed a Strategic Distributor and Partnership Agreement for products, including a sugar-free energy drink called “Nitro G,” in exchange for 797,000 restricted, unregistered shares of common stock valued approximately $1.34 million accounted as Intangible assets in second quarter of Fiscal 2019. Due to the U.S. Food & Drug Administration’s current general prohibition on the distribution of CBD-infused drinks, among others, the Company, in the fourth quarter of Fiscal 2019, elected to terminate the Strategic Distributor & Partnership Agreement.

NOTE 6 - PROPERTY, PLANT AND EQ

NOTE 6 - PROPERTY, PLANT AND EQUIPMENT	12 Months Ended
	Mar. 31, 2019
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	NOTE 6 – PROPERTY, PLANT, AND EQUIPMENT Property, plant, and equipment consist of the following: (in thousands) As of March 31, Category Useful Life (years) 2019 ($) 2018 ($) Land N/A 4,872 5,175 Buildings & facilities 25 1,268 955 Plant and machinery 20 1,603 1,703 Computer equipment 3 165 159 Office equipment 5 109 115 Furniture and fixtures 5 61 65 Vehicles 5 279 292 Facility under construction N/A - 374 Total Gross Value 8,357 8,838 Less: Accumulated depreciation (2,471 ) (2,601 ) Total Net PP&E 5,886 6,237 Depreciation expense for Fiscal 2019 and Fiscal 2018 were approximately $59 thousand and $19 thousand, respectively. Capital work-in-progress represents advances paid towards the acquisition of property and equipment and the cost of property and equipment not used before the balance sheet date.

NOTE 7 - INVESTMENTS IN UNLISTE

NOTE 7 - INVESTMENTS IN UNLISTED SECURITIES	12 Months Ended
	Mar. 31, 2019
Investments in and Advances to Affiliates, Schedule of Investments [Abstract]
Investments in and Advances to Affiliates, Schedule of Investments [Text Block]	NOTE 7 – INVESTMENTS IN UNLISTED SECURITIES Investments – others for each of the years ended March 31, 2019 and 2018 consist of the following: (in thousands) As of March 31, 2019 ($) 2018 ($) Investment in equity shares of unlisted company (i) 21 26 Investment in affiliate (ii) 773 773 Total 794 799 (i) The movement between the two reporting periods is based on the sale at cost of 1.34% of the investment in the amount of $5 thousand to a director of our subsidiary and fluctuations in the exchange rate. The investment is recorded at cost. (ii) Pursuant to the December 18, 2014 Purchase Agreement with Apogee, we issued Apogee 1,200 thousand shares of IGC’s common stock valued at $888 thousand for the purchase of a 24.9% ownership interest in Midtown Partners & Co., LLC (MTP). During Fiscal 2018, after considering several factors, the Company concluded that it no longer had significant influence over MTP. Hence, we did not record any impact of MTP’s earnings/(losses) and instead we maintained the same value as of March 31, 2017 or (approximately $773 thousand). The Company regularly reviews its investment portfolio to determine if any security is other-than-temporarily impaired, which would require the Company to record an impairment charge in the period. We concluded that, as at March 31, 2019, no impairment provision was required against the carrying value of the investments.

NOTE 8 - CLAIMS AND ADVANCES

NOTE 8 - CLAIMS AND ADVANCES	12 Months Ended
	Mar. 31, 2019
Disclosure Text Block Supplement [Abstract]
Other Assets Disclosure [Text Block]	NOTE 8 – CLAIMS AND ADVANCES (in thousands) As of March 31, Particulars 2019 ($) 2018 ($) Claims receivable (1) 404 - Non-current deposits 18 18 Other advances (2) 456 466 Total 878 484 (1) The claims receivables are due from the Cochin International Airport. Cochin International Airport is partially owned by the State Government of Kerala. The receivables have been due for periods in excess of one year as of March 31, 2019. The Company continues to carry the full value of the receivables without interest and without any impairment, because it believes that there is minimal risk that this organization will become insolvent and unable to make payment. From the Company’s past experience, Company believes it will be difficult to receive the amount in next 12 months due to time taken by legal proceedings and the option to appeal in higher jurisdiction. (2) Includes a loan of $200 thousand, to one of our manufacturers, for the purchase of equipment, at an annual interest rate of three percent (3%), due on April 1, 2021. On May 21, 2012, TBL entered into an agreement with Weave & Weave for the purchase of land valued at approximately $578 thousand. TBL gave Weave and Weave an advance of approximately $354 thousand. We believe the amount is unrecoverable and hence a provision has been created in Fiscal 2019.

NOTE 9 - ACCRUED LIABILITIES AN

NOTE 9 - ACCRUED LIABILITIES AND OTHERS	12 Months Ended
	Mar. 31, 2019
Accrued Liabilities Disclosure [Abstract]
Accrued Liabilities Disclosure [Text Block]	NOTE 9 – ACCRUED LIABILITIES AND OTHERS Accrued expenses consist of the following: (in thousands) As of March 31, Particulars 2019 ($) 2018 ($) Statutory payables 4 4 Salaries and other contribution 115 199 Provision for expenses 355 56 Other current liability 35 29 Total 509 288 Salaries and other contribution related liabilities consist of unpaid salary payable to employees. Provision for Expenses include provisions for the March quarter for legal, professional, and marketing expenses.

NOTE 10 - LOANS AND OTHER LIABI

NOTE 10 - LOANS AND OTHER LIABILITIES	12 Months Ended
	Mar. 31, 2019
Loans and Other Liabilities [Abstract]
Loans and Other Liabilities [Text Block]	NOTE 1 0 – LOANS AND OTHER LIABILIT IES Secured l oans: Since October 16, 2009, the Company had a note with Bricoleur Partners, L.P. (Bricoleur) in the amount of $2 million. On December 10, 2010, the Company repaid $200 thousand towards the principal amount, rendering the balance to $1.8 million. In Fiscal 2019, the Company issued 30,000 shares to Bricoleur, valued at $18 thousand, which was expensed. On December 27, 2018, the Company entered into a Settlement Agreement and Mutual Release with Bricoleur to settle the outstanding note for $1.5 million. The gain from the settlement in the amount of $300 thousand is recognized as Other Income. Short-term loan : Please refer to Note 13 for information about Related Party Transactions. Other Liability : (in thousands) As of March 31, 2019 ($) 2018 ($) Statutory reserve 15 15 Total 15 15 The statutory reserve is a gratuity reserve for employees in our subsidiaries in India.

NOTE 11 - COMMITMENTS AND CONTI

NOTE 11 - COMMITMENTS AND CONTINGENCY	12 Months Ended
	Mar. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	NOTE 1 1 – COMMITMENTS AND CONTINGENCIES The Company may be involved in legal proceedings, claims, and assessments arising in the ordinary course of business. Such matters are subject to many uncertainties, and outcomes are not predictable with assurance. There are no such matters that are deemed material to the consolidated financial statements as of March 31, 2019. As of March 31, 2019, several law firms had filed shareholder lawsuits, including two derivative suits, citing the NYSE American delisting proceedings and subsequent fall in share price. See Item 3, Legal Proceedings of this report for further information. The Company intends to vigorously defend against these actions. However, the exact amount of liability, if any, arising from such lawsuits cannot be determined at this stage. No provision has been made in the consolidated financial statements as of March 31, 2019. In the U.S., we provide health insurance, life insurance, and a 401(k) plan wherein the Company matches up to 6% of the employee’s pretax contribution up to a maximum annual amount determined by the IRS. In accordance with applicable Indian laws, the Company provides for gratuity, a defined benefit retirement plan (Gratuity Plan) covering certain categories of employees. The Gratuity Plan provides a lump sum payment to vested employees, at retirement or termination of employment, an amount based on the respective employee’s last drawn salary and the years of employment with the Company. In addition, employees receive benefits from a provident fund, a defined contribution plan. The employee and employer each make monthly contributions to the plan equal to 12% of the covered employee’s salary. The contribution is made to the Government’s provident fund. The Company has entered into indemnification agreements with its directors and executive officers. Under these agreements, the Company has agreed to indemnify such individuals to the fullest extent permitted by law against liabilities that arise by reason of their status as directors or officers of the Company, and to advance expenses incurred by such individuals in connection with related legal proceedings. It is not possible to determine the maximum potential amount of payments the Company could be required to make under these agreements due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each claim. While the Company maintains directors and officer’s liability insurance coverage, such insurance coverage may be insufficient to cover all losses or all types of claims that may arise.

NOTE 12 - SECURITIES

NOTE 12 - SECURITIES	12 Months Ended
	Mar. 31, 2019
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	NOTE 1 2 – SECURITIES Company’s securities and listings We have one security listed on the NYSE American: common stock, $.0001 par value (ticker symbol: IGC). This security is also available for trading on the Frankfurt, Stuttgart, and Berlin stock exchanges (ticker symbol: IGS1). We have redeemable warrants quoted on the OTC markets (ticker symbol: IGC.IW, CUSIP number 45408X118 expiring on March 8, 2021) to purchase common stock. As of March 31, 2019, the Company was authorized to issue up to 150,000,000 shares of common stock, par value $0.0001, and has 91,472 units and 39,501,407 shares of common stock issued and outstanding. The Company has 11,672,178 outstanding public warrants (IGC: IW) to purchase 1,167,217 shares of common stock by surrendering 10 warrants and a payment of $5.00 in exchange for each share of common stock. We have 91,472 units outstanding that can be separated into common stock and warrants. The Units are not listed on an exchange. Ten units may be separated into one share of common stock and 20 warrants (IGC: IW). The unit holders are requested to contact the Company or our transfer agent Continental Stock Transfer & Trust to separate their units into common stock and warrants. Securities update Private placement and public offering a) In Fiscal 2019, the Company completed a public offering of 5,898,656 shares listed on the NYSE American. The net proceeds from this transaction after underwriting discounts and commissions were approximately $28.5 million. b) In October 2018, the Company issued 869,565 shares amounting to approximately $1 million pursuant to a private placement. Business Operations a) During Fiscal 2019, the Company issued 107,133 shares of fully vested common stock pursuant to marketing agreements with service providers which were valued at approximately $52 thousand that were expensed and included in general & administrative expenses. b) On March 23, 2019, we sold our Malaysian subsidiary Cabaran Ultima and received back 80,000 shares of IGC common stock from the buyer of Cabaran. There was no operating activity or gain and loss in the subsidiary in Fiscal 2019. c) During Fiscal 2019, the Company issued 80,000 shares to a former affiliated individual as part of a settlement agreement. d) Options valued at $178 thousand to purchase 490,000 shares were exercised by our advisors.

NOTE 13- RELATED PARTY TRANSACT

NOTE 13- RELATED PARTY TRANSACTIONS	12 Months Ended
	Mar. 31, 2019
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	NOTE 1 3 – RELATED PARTY TRANSACTIONS We pay an affiliate of our CEO $4.5 thousand per month for office space and certain general and administrative services rendered in Maryland. In addition, we pay another affiliate of our CEO $6.1 thousand per month for office and facilities in Washington State. During Fiscal 2019, the total rent paid to the affiliates were approximately $54 thousand for the office space (and administrative services) in Maryland, and $73 thousand for the facilities in Washington State. We expect that these expenses will remain at approximately this level during Fiscal 2020. The Company’s total cash interest expense for Fiscal 2019 and Fiscal 2018 were approximately $14 thousand and $31 thousand respectively. As of March 31, 2019, the Company had one secured loan of $50 thousand due from related party at an annual interest rate of 15%. The assets of the Company secure the loan. During the year, the Company repaid $377 thousand in loans from related parties.

NOTE 14 - STOCK-BASED COMPENSAT

NOTE 14 - STOCK-BASED COMPENSATION	12 Months Ended
	Mar. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	NOTE 1 4 – STOCK-BASED COMPENSATION As of March 31, 2019, under the combined 2008 Omnibus Incentive Plan and the renewed 2018 Omnibus Incentive Plan, approximately 2.1 million shares of common stock have been awarded. Under the combined 2008 Omnibus Incentive Plan and the renewed 2018 Omnibus Incentive Plan, as of April 1, 2019, a total of 6,372,127 shares of common stock have been awarded, and there are no shares of common stock available for future grants of options or stock awards. In Fiscal 2019 and Fiscal 2018, we gave our advisors options to purchase 110,000 and 490,000 shares respectively. The options are fair valued using a Black-Scholes Pricing Model with the following assumptions: Granted in Fiscal 2019 Granted in Fiscal 2018 Expected life of options 5 years 7 years Vested options 100 % 100 % Risk free interest rate 0.70 % 0.70 % Expected volatility 119.5 % 119.5 % Expected dividend yield Nil Nil The amount recognized in the additional paid up capital with respect to our stock-based compensation plans and option-based compensation were as follows: Stock-based compensation (in thousands) Year ended March 31 201 9 ($) 201 8 ($) Cost of sales - 41 General and administrative (including research and development) 515 219 Total stock-based compensation to employees 515 260 Option-based compensation Cost of sales - 29 General and administrative (including research and development) 48 43 Intangible assets 11 21 Total option-based compensation to advisors & contractors $ 59 93 The cost associated with stock compensation to employees is allocated over the vesting period. Over the next fiscal year we expect to recognize a total of $667 thousand and $101 thousand of stock-based compensation and option-based compensation, respectively. Summary of Options Number of options for Fiscal 2019 (in thousands) Number of options for Fiscal 2018 (in thousands) Opening balance 650 160 Option granted during the period 110 490 Option exercised during the period (490 ) - Closing balance 270 650

NOTE 15 - EMPLOYEE BENEFITS

NOTE 15 - EMPLOYEE BENEFITS	12 Months Ended
	Mar. 31, 2019
Retirement Benefits [Abstract]
Pension and Other Postretirement Benefits Disclosure [Text Block]	NOTE 1 5 – EMPLOYEE BENEFITS In accordance with applicable Indian laws, the Company provides for gratuity, a defined benefit retirement plan (Gratuity Plan) covering certain categories of employees. The Gratuity Plan provides a lump sum payment to vested employees, at retirement or termination of employment, an amount based on the respective employee’s last drawn salary and the years of employment with the Company. (in thousands) Year Ended March 31, 201 9 ($) 201 8 ($) Projected Benefit Obligation (PBO) at the beginning of the year 15 12 Service cost 1 1 interest cost 1 1 Benefits paid - Actuarial (gain)/loss (1 ) 1 PBO at the end of the year 16 15 Funded status 15 14 Net gratuity cost for the years ended March 31, 2019 and 2018 included: (in thousands) Year Ended March 31, 201 9 ($) 201 8 ($) Service cost 1 - Interest cost 1 1 Expected return on plan assets (1 ) (1 ) Actuarial (gain)/loss (1 ) 1 Net gratuity cost - 1 The weighted average actuarial assumptions used to determine benefit obligations and net periodic gratuity cost are: Year Ended March 31, 201 9 201 8 Discount rate 7.50 % 7.50 % Rate of increase in compensation levels 7 % 7 % The Company assesses these assumptions with its projected long-term plans of growth and prevalent industry standards. The expected payout of the accumulated benefit obligation as of March 31 is as follows. (in thousands) As of March 31, 201 9 ($) 201 8 ($) Expected contribution during the year ending Year 1 5 5 Expected benefit payments for the years ending March 31: Year 2 2 2 Year 3 0.5 0.5 Year 4 4 4 Year 5 0.3 0.3 Thereafter 6 6 Provident fund

NOTE 16 - INCOME TAXES

NOTE 16 - INCOME TAXES	12 Months Ended
	Mar. 31, 2019
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	NOTE 1 6 – INCOME TAXES The Company calculates its provision for foreign, U.S. federal and state income taxes based on current tax law. The Tax Cuts and Jobs Act (tax reform) was enacted on December 22, 2017 (“Enactment Date”), and has several key provisions impacting accounting for and reporting of income taxes. The most significant provision reduces the U.S. corporate statutory tax rate from 35% to 21% beginning on January 1, 2018. As the Company maintains a full valuation allowance against its deferred tax assets, there is no income tax expense recorded related to this change other than the Federal AMT credit which are refundable due to the passage of tax reform. In accordance with Staff Accounting Bulletin 118 (“SAB 118”), income tax effects of the Tax Act may be refined upon obtaining, preparing, or analyzing additional information during the measurement period and such changes could be material. During the measurement period, provisional amounts may be adjusted for the effects, if any, of interpretative guidance issued after December 31, 2017, by U.S. regulatory and standard-setting bodies. While we are able to make reasonable estimates of the impact of the reduction in corporate rate and the deemed repatriation transition tax, the final impact of the Tax Act may differ from these estimates, due to, among other things, changes in our interpretations and assumptions, additional guidance that may be issued by the I.R.S., and actions we may take. We are continuing to gather additional information to determine the final impact. Due to the Company’s history of losses and uncertainty of future taxable income, a valuation allowance sufficient to fully offset net operating losses and other deferred tax assets has been established. The valuation allowance will be maintained until sufficient positive evidence exists to support a conclusion that a valuation allowance is not necessary. Income tax expense/(benefit) for each of the years ended March 31 consists of the following: (in thousands) As of March 31, 201 9 ($) 201 8 ($) Current: Federal - - Foreign 2 1 State - - Net Current 2 1 Deferred: Federal - - Foreign - - State - - Net Deferred Total tax provision 2 1 The significant components of deferred income tax expense/(benefit) from operations before non-controlling interest for each of the years ended March 31 are approximated as following: (in thousands) As of March 31, 201 9 ($) 201 8 ($) Deferred tax expense/(benefit) - - Net operating loss carry forward 758 577 Foreign Tax Credits - - Less: Valuation Allowance 758 577 Net deferred tax expense - - The table below sets forth the approximate income tax expense/(benefit) for 2019 and 2018 computed by applying the applicable U.S. federal income tax rate and is reconciled to the tax expense/(benefit) computed at the effective income tax rate: (in thousands) As of March 31, 201 9 ($) 201 8 ($) Computed expected income tax expense/(benefit) 758 $ 577 State tax benefit net of federal tax - - Change in valuation allowance 758 577 Deferred expenses from foreign acquisition - - Impairment loss on goodwill - - Impairment loss on investments - - Capitalized interest costs - - Deferred tax assets from foreign subsidiaries - - Other - - Effective income tax rate (0.0 %) (0.0 %) Realization of deferred tax assets, including those related to net operating loss carryforwards, are dependent upon future earnings, if any, of which the timing and amount are uncertain. Accordingly, the net deferred tax assets have been fully offset by a valuation allowance. Based upon the Company’s current operating results management cannot conclude that it is more likely than not that such assets will be realized. The Company files income tax returns in India, Hong Kong and the U.S.

NOTE 17 - SEGMENT INFORMATION

NOTE 17 - SEGMENT INFORMATION	12 Months Ended
	Mar. 31, 2019
Segment Reporting [Abstract]
Segment Reporting Disclosure [Text Block]	NOTE 1 7 – SEGMENT INFORMATION FASB ASC No. 280, “Segment Reporting” establishes standards for reporting information about reportable segments. Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision-making group (CODM), in deciding how to allocate resources and in assessing performance. The CODM evaluates revenues and gross profits based on product lines and routes to market. Based on our integration and management strategies, we operate in two reportable segments: (i) Infrastructure Business and (ii) Plant and Cannabinoids Business. The Company’s CODM is considered to be the Company’s chief executive officer (CEO). The CEO reviews financial information presented on an operating segment basis for purposes of making operating decisions and assessing financial performance. Therefore, and before our Plant and Cannabinoid Business started, the Company had determined that it operated in a single operating and reportable segment. As of the date of this report and in preparation for the new and different source of revenue, the Company has determined that it operates in two operating and reportable segments: a) Infrastructure Business and b) and Plant and Cannabinoid Business. The following provides information required by ASC 280-10-50-38 Entity-Wide Information: 1) The table below shows revenue reported by segments: Product & Service Segments Fiscal 2019 (in thousands) ($) Percentage of Total Revenue Infrastructure Business 5,091 99 % Plant and Cannabinoid Business 25 1 % Total 5,116 100 % Segments Fiscal 2018 (in thousands) ($) Percentage of Total Revenue Infrastructure Business 2,193 100 % Plant and Cannabinoid Business - 0 % Total 2,193 100 % 2(a) The table below shows the revenue attributed to the country of domicile (U.S.) and foreign countries. Revenue is generally attributed to the location of customers located in those geographic locations. Segments Country Fiscal 2019 (in thousands) ($) Percentage of Total Revenue Asia (1) India 70 1 % (2) Hong Kong 5,021 98 % North America U.S. 25 1 % Total 5,116 100 % Country Fiscal 2018 (in thousands) ($) Percentage of Total Revenue Asia (1) India 396 18 % (2) Hong Kong 1,797 82 % North America U.S. - 0 % Total 2,193 100 % 2(b) The table below shows the non-current assets other than financial instruments held in the country of domicile and foreign countries (in thousands). Nature of Assets USA (Country of Domicile) ($) Foreign Countries (India) ($) Total for the Fiscal 2019 ($) Intangible assets, net 184 - 184 Property, plant and equipment, net 958 4,928 5,886 Investments in unlisted securities 773 21 794 Claims and advances 440 438 878 Total long-term assets 2,355 5,387 7,742 Nature of Assets USA (Country of Domicile) ($) Foreign Countries (India) ($) Total for Fiscal 2018 ($) Intangible assets, net 128 128 Property, plant and equipment, net 1,001 5,236 6,237 Investments in unlisted securities 773 26 799 Claims and advances - 484 484 Total long-term assets 1,902 5,746 7,648

NOTE 18 - SUBSEQUENT EVENTS

NOTE 18 - SUBSEQUENT EVENTS	12 Months Ended
	Mar. 31, 2019
Subsequent Events [Abstract]
Subsequent Events [Text Block]	NOTE 1 8 – SUBSEQUENT EVENTS On May 13, 2019, the Company entered into an agreement with Alzheimer’s’ Prevention Clinic & Research Center Puerto Rico PBC for phase 2 trials related to IGC-AD1. On May 17, 2019, the Company, through its wholly owned subsidiary Holi Hemp LLC, entered into a cultivation agreement for growing and farming of hemp on 100 Acre land in Arizona. Additional Shareholder Derivative Action Litigation: Patel v. Mukunda, et al., 8:19-cv-01673 (U.S. District Court for the District of Maryland) On June 6, 2019, IGC shareholder Dimple Patel instituted a shareholder derivative complaint on behalf of IGC in the United States District Court for the District of Maryland. Ram Mukunda, Claudia Grimaldi, Rohit Goel, Richard Prins, Shajy Mathilakathu, and Sudhakar Shenoy were named as defendants, and IGC was named as a nominal defendant. The Patel litigation represents a claim made by a shareholder on behalf of the Company (as opposed to against the Company). The complaint in the Patel litigation alleges that the Company should have filed suit against the individual defendants – Mukunda, Grimaldi, Goel, Prins, Mathilakathu, and Shenoy (collectively referred to as the “Individual Defendants”) – for breach of fiduciary duty. Specifically, the complaint alleges that the Individual Defendants “violated their duty of good faith by knowingly causing and/or recklessly allowing the Company to make false and misleading statements and/or fail[ed] to disclose that: (i) [IGC] substantially discontinued the business that it conducted at the time it began trading on the NYSE; (ii) the Company had become engaged in ventures or promotions which have not developed to a commercial stage; (iii) cannabis-related products, including CBD-based beverages, are illegal in Malaysia; (iv) neither IGC nor Treasure Network was a licensed manufacturer of cannabis-based products in Malaysia; (v) CBD-infused Nitro G was not an approved and registered product under Malaysian law; (vi) Treasure Network, founded in 2017, was not “experienced”; (vii) Treasure Network was a distributor, not a manufacturer; (viii) at all relevant times, the Individual Defendants had the ability to exercise substantial control over Treasure Network; (ix) consequently, the Company was not an operating company for the purposes of continued trading and listing on the NYSE American; and (x) as a result, India Globalization’s public statements were materially false and misleading at all relevant times.” Because the claims made in the Patel litigation are asserted against the individual defendants, as opposed to the Company, the Company is merely a nominal defendant. The Company will monitor the case and proceed as appropriate under the circumstances as and if the matter progresses. The Company has retained counsel for that purpose. The Company anticipates that it may seek to consolidate the Patel litigation with the Erny derivative litigation described herein.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	12 Months Ended
	Mar. 31, 2019
Accounting Policies [Abstract]
Consolidation, Policy [Policy Text Block]	Principles of consolidation The consolidated financial statements include the accounts of the Company and all of its subsidiaries. Intercompany accounts and transactions have been eliminated. In the opinion of the Company’s management, the consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. Transactions between the Company and its subsidiaries are eliminated in the consolidated financial statements.
Reclassification, Policy [Policy Text Block]	Reclassifications Certain prior period amounts in the consolidated financial statements and accompanying notes have been reclassified to conform to the current period’s presentation. Certain aged receivables and certain deposits and advances in the amount of approximately $644 thousand have been reclassified to non-current assets from current assets. In Fiscal 2019, a Note Payable in the amount of $1.8 Million has been paid off. Please see “Note 10 – Loans and Other Liabilities”, in our Notes to Consolidated Financial Statements contained herein for more information.
Use of Estimates, Policy [Policy Text Block]	Use of estimates The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Management believes that the estimates and assumptions used in the preparation of the consolidated financial statements are prudent and reasonable. Significant estimates and assumptions are generally used for, but not limited to: allowance for uncollectible accounts receivable; future obligations under employee benefit plans; the useful lives of property, plant, equipment; intangible assets; valuations; impairment of goodwill and investments; recoverability of advances; the valuation of options granted and warrants issued; and income tax and deferred tax valuation allowances, if any. Actual results could differ from those estimates. Appropriate changes in estimates are made as management becomes aware of changes in circumstances surrounding the estimates. Critical accounting estimates could change from period to period and could have a material impact on IGC’s results, operations, financial position and cash flows. Changes in estimates are reflected in the financial statements in the period in which changes are made and, if material, their effects are disclosed in the notes to the consolidated financial statements.
Revenue Recognition, Policy [Policy Text Block]	Revenue recognition The Company recognizes revenue under ASC 606, Revenue from Contracts with Customers ASC 606 prescribes a 5-step process to achieve its core principle. The Company recognizes revenue from trading, rental, or product sales as follows: I. Identify the contract with the customer. II. Identify the contractual performance obligations. III. Determine the amount of consideration/price for the transaction. IV. Allocate the determined amount of consideration/price to the contractual obligations. V. Recognize revenue when or as the performing party satisfies performance obligations. The consideration/price for the transaction (performance obligation(s)) is determined as per the agreement or invoice (contract) for the services and products in the Infrastructure Business and Plant and Cannabinoid Business. Revenue in the Infrastructure Business is recognized for the renting and contracting business once the obligation as per the agreement has been completed by the company. The revenue from the purchase and resale of physical infrastructure commodities is recognized once the bill of lading along with the invoice have been transferred to the customer. In the Plant and Cannabinoid Business, the revenue from the cannabinoid-based products is recognized in Holi Hemp once goods have been sold to the customer and the performance obligation has been completed. While in IGCare, we license our products to processors. The revenue from the cannabinoid-based products and therapies is recognized once goods have been sold to the customer by the outlets and the performance obligation is completed as per the agreement. Net sales disaggregated by significant products and services for Fiscal 2019 and Fiscal 2018 were as follows (in thousands): Year Ended March 31, 2019 ($) 2018 ($) Infrastructure Business Rental income (1) 30 45 Construction contracts (2) - 62 Purchase and resale of physical commodities (3) 5,061 2,086 Plant and Cannabinoid Business Cannabinoid products and therapies (4) 25 - Total 5,116 2,193 (1) Rental income consists of income from rental of heavy construction equipment like bulldozers, excavators, rollers and pavers, among others. (2) Relates to the income from execution of construction contracts. (3) Relates to the income from purchase and resale of physical commodities used in infrastructure, like steel, marble and tiles. (4) Relates to the revenue from plant and cannabinoid-based products and therapies such as hemp crude extract, hemp isolate, and hemp distillate. There was no revenue from Hyalolex™ During Fiscal 2019 and 2018, the Company had approximately $5,091 thousand and $2,193 thousand of revenue respectively in Infrastructure Business. During Fiscal 2019, the Company reported $25 thousand in revenue from the Plant and Cannabinoid Business.
Earnings Per Share, Policy [Policy Text Block]	Basic and diluted loss per share Basic loss per common share is computed by dividing net loss available to common stockholders by the weighted average number of common stock outstanding. Diluted loss per common share is computed similar to basic loss per common share except that the denominator is increased to include the number of additional shares of common stock that would have been outstanding if the potential common stock had been issued and if the additional shares of common stock were dilutive. The weighted average number of shares outstanding for Fiscal 2019 and Fiscal 2018 used for the computation of basic EPS is 35,393,407 and 27,937,287 shares, respectively. Potential common stock consists of the incremental common stock issuable upon the exercise of common stock warrants (using the if-converted method). The computation of basic loss per share for the year ended March 31, 2019 excludes potentially dilutive securities of 3.3 million shares underlying common stock, warrants and options, because their inclusion would be antidilutive. As a result, the computations of net loss per share for each period presented is the same for both basic and fully diluted.
Income Tax, Policy [Policy Text Block]	Income taxes The Company accounts for income taxes under the asset and liability method, in accordance with ASC 740, Income Taxes, which requires an entity to recognize deferred tax liabilities and assets. Deferred tax assets and liabilities are recognized for the future tax consequence attributable to the differences between the financial statement carrying amounts of existing assets and liabilities and their tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the enacted tax rate expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. A valuation allowance is established and recorded when management determines that some or all of the deferred tax assets are not likely to be realized and therefore, it is necessary to reduce deferred tax assets to the amount expected to be realized. In evaluating a tax position for recognition, management evaluates whether it is more-likely-than-not that a position will be sustained upon examination, including resolution of related appeals or litigation processes, based on technical merits of the position. If the tax position meets the more-likely-than-not recognition threshold, the tax position is measured and recognized in the Company’s financial statements as the largest amount of tax benefit that, in management’s judgment, is greater than 50% likely of being realized upon settlement. As of March 31, 2019, and 2018, there was no significant liability for income tax associated with unrecognized tax benefits.
Receivables, Policy [Policy Text Block]	Accounts receivable Accounts receivable represents amounts owed from customers in the Infrastructure Business. The Company estimates reserves for bad debts based on general aging, experience and past-due status of the accounts. The allowance for doubtful accounts is determined by evaluating the relative credit worthiness of each client, historical collections experience and other information, including the aging of the receivables.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and cash equivalents For financial statement purposes, the Company considers all highly liquid debt instruments with maturity of three months or less, to be cash equivalents. The Company maintains its cash in bank accounts in the U.S., India, and Hong Kong, which at times may exceed applicable insurance limits. The cash in foreign subsidiaries as on March 31, 2019 and 2018, was approximately $284 thousand and $30 thousand, respectively.
Investment, Policy [Policy Text Block]	Short-term and long-term investments Our policy for short-term and long-term investments is to establish a high-quality portfolio that preserves principal, meets liquidity needs, avoids inappropriate concentrations and delivers an appropriate yield in relationship to our investment guidelines and market conditions. Short-term and long-term investments consist of corporate, various government agency and municipal debt securities, as well as certificates of deposit that have maturity dates that are greater than 90 days. Certificates of deposit and commercial paper are carried at cost which approximates fair value. We classify our marketable securities as available-for-sale in accordance with FASB ASC Topic 320, “Investments — Debt and Equity Securities”. Available-for-sale securities are carried at fair value with unrealized gains and losses reported in stockholders’ equity, net of related tax effects. Other Investments are initially measured at cost, which is the fair value of the consideration given for them, including transaction costs. The Company’s equity in the earnings/(losses) of affiliates is included in the statement of income and the Company’s share of net assets of affiliates is included in the balance sheet. Where the Company’s ownership interest is in excess of 25% and the Company enjoys significant interest, the Company has accounted for the investment based on the equity method. In Fiscal 2019 and 2018, the Company concluded that it does not have significant influence over Midtown Partner LLC (MTP). Therefore, the Company did not recognize any changes in MTP’s earnings/(losses). The investment is valued at the same value as in Fiscal 2017.
Property, Plant and Equipment, Policy [Policy Text Block]	Property, plant and equipment (PP&E) Property and equipment are recorded at cost net of accumulated depreciation and depreciated over their estimated useful lives using the straight-line method. Upon retirement or disposition, cost and related accumulated depreciation of the property and equipment are de-recognized and any gain or loss is reflected in the results of operation. Cost of additions and substantial improvements to property and equipment are capitalized. The cost of maintenance and repairs of the property and equipment are charged to operating expenses as incurred.
Fair Value Measurement, Policy [Policy Text Block]	Fair value of financial instruments FASB ASC No. 820, “Fair Value Measurement” defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. It also establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: Level 1: Observable inputs such as quoted prices in active markets; Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. The carrying amounts of the Company’s financial instrument includes cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities, approximate their fair values due to the nature of the items. As of March 31, 2019, the Company’s investments are Level 3 instruments. Financial instruments are classified as current if they are expected to be liquidated within the next twelve months. For further information refer Note 7 – Investments in Unlisted Securities.
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Concentration of credit risk and significant customers Financial instruments, which potentially expose the Company to concentrations of credit risk, are primarily comprised of cash and cash equivalents, investments, accounts receivable and unbilled accounts receivable, if any. The Company places its cash, investments in highly rated financial institutions. The Company adheres to a formal investment policy with the primary objective of preservation of principal, which contains credit rating minimums and diversification requirements. Management believes its credit policies reflect normal industry terms and business risk. The Company does not anticipate non-performance by the counterparties and, accordingly, does not require collateral. During Fiscal 2019, sales were spread across customers in Asia and U.S. and the credit concentration risk is low.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock – Based Compensation The Company accounts for stock-based compensation to employees and non-employees in conformity with the provisions of ASC 718, Stock-Based Compensation
Commitments and Contingencies, Policy [Policy Text Block]	Commitments and contingencies Liabilities for loss contingencies arising from claims, assessments, litigations, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment and/or remediation can be reasonably estimated. We record associated legal fees as incurred. Information regarding our commitments and contingencies is incorporated by reference in Note 11 of this annual report on Form 10-K
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	Impairment of long – lived assets The Company reviews its long-lived assets, with finite lives, for impairment whenever events or changes in business circumstances indicate that the carrying amount of assets may not be fully recoverable. Such circumstances include, though are not limited to, significant or sustained declines in revenues or earnings, future anticipated cash flows, business plans and material adverse changes in the economic climate, such as changes in operating environment, competitive information and impact of changes in government policies. For assets that the Company intends to hold for use, if the total of the expected future undiscounted cash flows produced by the assets or subsidiary company is less than the carrying amount of the assets, a loss is recognized for the difference between the fair value and carrying value of the assets. For assets the Company intends to dispose of by sale, a loss is recognized for the amount by which the estimated fair value less cost to sell is less than the carrying value of the assets. Fair value is determined based on quoted market prices, if available, or other valuation techniques including discounted future net cash flows. Unlike goodwill, long-lived assets are assessed for impairment only where there are any specific indicators for impairment.
Inventory, Policy [Policy Text Block]	Inventor y Inventory, consisting of products available for sale, are primarily accounted for using the first-in first-out method, and are valued at the lower of cost or market, the term market means current replacement cost, provided that it meets both the following conditions: a) market shall not exceed the net realizable value, and b) market shall not be less than net realizable value reduced by an allowance for an approximately normal profit margin. This valuation requires us to make judgments, based on currently available information, about the likely method of disposition, such as through sales to individual customers, returns to product vendors, or liquidations, and expected recoverable values of each disposition category. These assumptions about future disposition of inventory are inherently uncertain and changes in our estimates and assumptions may cause us to realize material write-downs in the future.
Cyber-security Policy [Policy Text Block]	Cyber s ecurity We have a cybersecurity policy in place and tighter cybersecurity measures to safeguard against hackers. In Fiscal 2019, there were no impactful breaches in cybersecurity.
Derivatives, Policy [Policy Text Block]	Hedging The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risks. The Company evaluates its financial instruments, including equity-linked financial instruments, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives
Research, Development, and Computer Software, Policy [Policy Text Block]	Research and Development Expenses During Fiscal 2019 and Fiscal 2018, the Company recorded research and development expense of approximately $1,256 thousand and $137 thousand respectively. All research and development costs are expensed in the period in which they are incurred.
New Accounting Pronouncements, Policy [Policy Text Block]	Recently issued and adopted accounting pronouncements Changes to U.S. GAAP are established by the Financial Accounting Standards Board (FASB) in the form of accounting standards updates (ASUs) to the FASB’s Accounting Standards Codification. The Company considers the applicability and impact of all ASUs. Newly issued ASUs not listed below are expected to have no impact on the Company’s consolidated financial position and results of operations, because either the ASU is not applicable, or the impact is expected to be immaterial. Adopted Business Combination: Reporting Comprehensive Income: Stock-Based Compensation Not yet adopted Credit Losses: Leases: D isclosures:

NOTE 2 - SIGNIFICANT ACCOUNTI_2

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Mar. 31, 2019
Accounting Policies [Abstract]
Reconciliation of Revenue from Segments to Consolidated [Table Text Block]	Net sales disaggregated by significant products and services for Fiscal 2019 and Fiscal 2018 were as follows (in thousands): Year Ended March 31, 2019 ($) 2018 ($) Infrastructure Business Rental income (1) 30 45 Construction contracts (2) - 62 Purchase and resale of physical commodities (3) 5,061 2,086 Plant and Cannabinoid Business Cannabinoid products and therapies (4) 25 - Total 5,116 2,193 (1) Rental income consists of income from rental of heavy construction equipment like bulldozers, excavators, rollers and pavers, among others. (2) Relates to the income from execution of construction contracts. (3) Relates to the income from purchase and resale of physical commodities used in infrastructure, like steel, marble and tiles. (4) Relates to the revenue from plant and cannabinoid-based products and therapies such as hemp crude extract, hemp isolate, and hemp distillate. There was no revenue from Hyalolex™

NOTE 3 - INVENTORY (Tables)

NOTE 3 - INVENTORY (Tables)	12 Months Ended
	Mar. 31, 2019
Inventory Disclosure [Abstract]
Schedule of Inventory, Current [Table Text Block]	(in thousands) As of March 31, 2019 ($) 2018 ($) WIP 248 486 Total 248 486

NOTE 4 - DEPOSITS AND ADVANCES

NOTE 4 - DEPOSITS AND ADVANCES (Tables)	12 Months Ended
	Mar. 31, 2019
Deposits and Advances [Abstract]
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]	(in thousands) As of March 31, 201 9 ($) 201 8 ($) Advance to suppliers and consultants 720 300 Statutory advances 43 44 Other current assets 18 11 Total 781 355

NOTE 5 - INTANGIBLE ASSETS (Tab

NOTE 5 - INTANGIBLE ASSETS (Tables)	12 Months Ended
	Mar. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets and Goodwill [Table Text Block]	(in thousands) As of March 31, 2019 ($) 2018 ($) Patent & other intangible assets at the beginning of the period 128 - Patent acquisition and filing expenses for 12 months (Net) 56 128 Total 184 128 (i) The value of intangibles include the acquisition of patent rights, data, and the filing of patents. The amortization of acquired patent rights is 13 years from Fiscal 2020. There was no amortization of intangible assets during Fiscal 2019 and Fiscal 2018.

NOTE 6 - PROPERTY, PLANT AND _2

NOTE 6 - PROPERTY, PLANT AND EQUIPMENT (Tables)	12 Months Ended
	Mar. 31, 2019
Property Plant and Equipment Table [Member]
NOTE 6 - PROPERTY, PLANT AND EQUIPMENT (Tables) [Line Items]
Property, Plant and Equipment [Table Text Block]	Property, plant, and equipment consist of the following: (in thousands) As of March 31, Category Useful Life (years) 2019 ($) 2018 ($) Land N/A 4,872 5,175 Buildings & facilities 25 1,268 955 Plant and machinery 20 1,603 1,703 Computer equipment 3 165 159 Office equipment 5 109 115 Furniture and fixtures 5 61 65 Vehicles 5 279 292 Facility under construction N/A - 374 Total Gross Value 8,357 8,838 Less: Accumulated depreciation (2,471 ) (2,601 ) Total Net PP&E 5,886 6,237

NOTE 7 - INVESTMENTS IN UNLIS_2

NOTE 7 - INVESTMENTS IN UNLISTED SECURITIES (Tables)	12 Months Ended
	Mar. 31, 2019
Investments in and Advances to Affiliates, Schedule of Investments [Abstract]
Investment [Table Text Block]	Investments – others for each of the years ended March 31, 2019 and 2018 consist of the following: (in thousands) As of March 31, 2019 ($) 2018 ($) Investment in equity shares of unlisted company (i) 21 26 Investment in affiliate (ii) 773 773 Total 794 799 (i) The movement between the two reporting periods is based on the sale at cost of 1.34% of the investment in the amount of $5 thousand to a director of our subsidiary and fluctuations in the exchange rate. The investment is recorded at cost. (ii) Pursuant to the December 18, 2014 Purchase Agreement with Apogee, we issued Apogee 1,200 thousand shares of IGC’s common stock valued at $888 thousand for the purchase of a 24.9% ownership interest in Midtown Partners & Co., LLC (MTP). During Fiscal 2018, after considering several factors, the Company concluded that it no longer had significant influence over MTP. Hence, we did not record any impact of MTP’s earnings/(losses) and instead we maintained the same value as of March 31, 2017 or (approximately $773 thousand).

NOTE 8 - CLAIMS AND ADVANCES (T

NOTE 8 - CLAIMS AND ADVANCES (Tables)	12 Months Ended
	Mar. 31, 2019
Disclosure Text Block Supplement [Abstract]
Schedule of Other Assets, Noncurrent [Table Text Block]	(in thousands) As of March 31, Particulars 2019 ($) 2018 ($) Claims receivable (1) 404 - Non-current deposits 18 18 Other advances (2) 456 466 Total 878 484 (1) The claims receivables are due from the Cochin International Airport. Cochin International Airport is partially owned by the State Government of Kerala. The receivables have been due for periods in excess of one year as of March 31, 2019. The Company continues to carry the full value of the receivables without interest and without any impairment, because it believes that there is minimal risk that this organization will become insolvent and unable to make payment. From the Company’s past experience, Company believes it will be difficult to receive the amount in next 12 months due to time taken by legal proceedings and the option to appeal in higher jurisdiction. (2) Includes a loan of $200 thousand, to one of our manufacturers, for the purchase of equipment, at an annual interest rate of three percent (3%), due on April 1, 2021. On May 21, 2012, TBL entered into an agreement with Weave & Weave for the purchase of land valued at approximately $578 thousand. TBL gave Weave and Weave an advance of approximately $354 thousand. We believe the amount is unrecoverable and hence a provision has been created in Fiscal 2019.

NOTE 9 - ACCRUED LIABILITIES _2

NOTE 9 - ACCRUED LIABILITIES AND OTHERS (Tables)	12 Months Ended
	Mar. 31, 2019
Accrued Liabilities Disclosure [Abstract]
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]	Accrued expenses consist of the following: (in thousands) As of March 31, Particulars 2019 ($) 2018 ($) Statutory payables 4 4 Salaries and other contribution 115 199 Provision for expenses 355 56 Other current liability 35 29 Total 509 288

NOTE 10 - LOANS AND OTHER LIA_2

NOTE 10 - LOANS AND OTHER LIABILITIES (Tables)	12 Months Ended
	Mar. 31, 2019
Loans and Other Liabilities [Abstract]
Schedule of Other Assets and Other Liabilities [Table Text Block]	Other Liability: (in thousands) As of March 31, 2019 ($) 2018 ($) Statutory reserve 15 15 Total 15 15

NOTE 14 - STOCK-BASED COMPENS_2

NOTE 14 - STOCK-BASED COMPENSATION (Tables)	12 Months Ended
	Mar. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]	The options are fair valued using a Black-Scholes Pricing Model with the following assumptions: Granted in Fiscal 2019 Granted in Fiscal 2018 Expected life of options 5 years 7 years Vested options 100 % 100 % Risk free interest rate 0.70 % 0.70 % Expected volatility 119.5 % 119.5 % Expected dividend yield Nil Nil
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]	The amount recognized in the additional paid up capital with respect to our stock-based compensation plans and option-based compensation were as follows: Stock-based compensation (in thousands) Year ended March 31 201 9 ($) 201 8 ($) Cost of sales - 41 General and administrative (including research and development) 515 219 Total stock-based compensation to employees 515 260 Option-based compensation Cost of sales - 29 General and administrative (including research and development) 48 43 Intangible assets 11 21 Total option-based compensation to advisors & contractors $ 59 93
Share-based Compensation, Stock Options, Activity [Table Text Block]	Summary of Options Number of options for Fiscal 2019 (in thousands) Number of options for Fiscal 2018 (in thousands) Opening balance 650 160 Option granted during the period 110 490 Option exercised during the period (490 ) - Closing balance 270 650

NOTE 15 - EMPLOYEE BENEFITS (Ta

NOTE 15 - EMPLOYEE BENEFITS (Tables)	12 Months Ended
	Mar. 31, 2019
Retirement Benefits [Abstract]
Schedule of Changes in Accumulated Postemployment Benefit Obligations [Table Text Block]	In accordance with applicable Indian laws, the Company provides for gratuity, a defined benefit retirement plan (Gratuity Plan) covering certain categories of employees. The Gratuity Plan provides a lump sum payment to vested employees, at retirement or termination of employment, an amount based on the respective employee’s last drawn salary and the years of employment with the Company. (in thousands) Year Ended March 31, 201 9 ($) 201 8 ($) Projected Benefit Obligation (PBO) at the beginning of the year 15 12 Service cost 1 1 interest cost 1 1 Benefits paid - Actuarial (gain)/loss (1 ) 1 PBO at the end of the year 16 15 Funded status 15 14
Schedule of Net Benefit Costs [Table Text Block]	Net gratuity cost for the years ended March 31, 2019 and 2018 included: (in thousands) Year Ended March 31, 201 9 ($) 201 8 ($) Service cost 1 - Interest cost 1 1 Expected return on plan assets (1 ) (1 ) Actuarial (gain)/loss (1 ) 1 Net gratuity cost - 1
Schedule of Assumptions Used [Table Text Block]	The weighted average actuarial assumptions used to determine benefit obligations and net periodic gratuity cost are: Year Ended March 31, 201 9 201 8 Discount rate 7.50 % 7.50 % Rate of increase in compensation levels 7 % 7 %
Schedule of Expected Benefit Payments [Table Text Block]	The expected payout of the accumulated benefit obligation as of March 31 is as follows. (in thousands) As of March 31, 201 9 ($) 201 8 ($) Expected contribution during the year ending Year 1 5 5 Expected benefit payments for the years ending March 31: Year 2 2 2 Year 3 0.5 0.5 Year 4 4 4 Year 5 0.3 0.3 Thereafter 6 6

NOTE 16 - INCOME TAXES (Tables)

NOTE 16 - INCOME TAXES (Tables)	12 Months Ended
	Mar. 31, 2019
NOTE 16 - INCOME TAXES (Tables) [Line Items]
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	Income tax expense/(benefit) for each of the years ended March 31 consists of the following: (in thousands) As of March 31, 201 9 ($) 201 8 ($) Current: Federal - - Foreign 2 1 State - - Net Current 2 1 Deferred: Federal - - Foreign - - State - - Net Deferred Total tax provision 2 1
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	The table below sets forth the approximate income tax expense/(benefit) for 2019 and 2018 computed by applying the applicable U.S. federal income tax rate and is reconciled to the tax expense/(benefit) computed at the effective income tax rate: (in thousands) As of March 31, 201 9 ($) 201 8 ($) Computed expected income tax expense/(benefit) 758 $ 577 State tax benefit net of federal tax - - Change in valuation allowance 758 577 Deferred expenses from foreign acquisition - - Impairment loss on goodwill - - Impairment loss on investments - - Capitalized interest costs - - Deferred tax assets from foreign subsidiaries - - Other - - Effective income tax rate (0.0 %) (0.0 %)
Parent Company [Member]
NOTE 16 - INCOME TAXES (Tables) [Line Items]
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	The significant components of deferred income tax expense/(benefit) from operations before non-controlling interest for each of the years ended March 31 are approximated as following: (in thousands) As of March 31, 201 9 ($) 201 8 ($) Deferred tax expense/(benefit) - - Net operating loss carry forward 758 577 Foreign Tax Credits - - Less: Valuation Allowance 758 577 Net deferred tax expense - -

NOTE 17 - SEGMENT INFORMATION (

NOTE 17 - SEGMENT INFORMATION (Tables)	12 Months Ended
	Mar. 31, 2019
Segment Reporting [Abstract]
Revenue from External Customers by Products and Services [Table Text Block]	The table below shows revenue reported by segments: Segments Fiscal 2019 (in thousands) ($) Percentage of Total Revenue Infrastructure Business 5,091 99 % Plant and Cannabinoid Business 25 1 % Total 5,116 100 % Segments Fiscal 2018 (in thousands) ($) Percentage of Total Revenue Infrastructure Business 2,193 100 % Plant and Cannabinoid Business - 0 % Total 2,193 100 %
Revenue from External Customers by Geographic Areas [Table Text Block]	Revenue is generally attributed to the location of customers located in those geographic locations. Segments Country Fiscal 2019 (in thousands) ($) Percentage of Total Revenue Asia (1) India 70 1 % (2) Hong Kong 5,021 98 % North America U.S. 25 1 % Total 5,116 100 % Country Fiscal 2018 (in thousands) ($) Percentage of Total Revenue Asia (1) India 396 18 % (2) Hong Kong 1,797 82 % North America U.S. - 0 % Total 2,193 100 %
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]	The table below shows the non-current assets other than financial instruments held in the country of domicile and foreign countries (in thousands). Nature of Assets USA (Country of Domicile) ($) Foreign Countries (India) ($) Total for the Fiscal 2019 ($) Intangible assets, net 184 - 184 Property, plant and equipment, net 958 4,928 5,886 Investments in unlisted securities 773 21 794 Claims and advances 440 438 878 Total long-term assets 2,355 5,387 7,742 Nature of Assets USA (Country of Domicile) ($) Foreign Countries (India) ($) Total for Fiscal 2018 ($) Intangible assets, net 128 128 Property, plant and equipment, net 1,001 5,236 6,237 Investments in unlisted securities 773 26 799 Claims and advances - 484 484 Total long-term assets 1,902 5,746 7,648

NOTE 1 - NATURE OF OPERATIONS_2

NOTE 1 - NATURE OF OPERATIONS AND MANAGEMENT’S PLANS (Details)	Mar. 23, 2019shares	Mar. 31, 2019	Mar. 31, 2018
NOTE 1 - NATURE OF OPERATIONS AND MANAGEMENT’S PLANS (Details) [Line Items]
Number of New Subsidiaries		3	1
Cancellation of IGC shares as Consideration of Cabaran Ultima [Member]
NOTE 1 - NATURE OF OPERATIONS AND MANAGEMENT’S PLANS (Details) [Line Items]
Stock Repurchased During Period, Shares (in Shares)	80,000

NOTE 2 - SIGNIFICANT ACCOUNTI_3

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]
Prior Period Reclassification Adjustment	$ 644
Repayments of Notes Payable	1,800
Revenues	$ 5,116	$ 2,193
Weighted Average Number of Shares Outstanding, Basic (in Shares)	35,393,407	27,937,287
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)	3,300,000
Cumulative Effect of New Accounting Principle in Period of Adoption	$ 30
Research and Development Expense	1,256	$ 137
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	30
Foreign Subsidiaries [Member]
NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]
Cash	284	30
Legacy Infrastructure [Member]
NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]
Revenues	5,091	$ 2,193
Plant and Cannabinoid [Member]
NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]
Revenues	$ 25

NOTE 2 - SIGNIFICANT ACCOUNTI_4

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (Details) - Reconciliation of Revenue from Segments to Consolidated - USD ($) $ in Thousands		12 Months Ended
		Mar. 31, 2019	Mar. 31, 2018
Infrastructure Business
Net Sales by segments		$ 5,116	$ 2,193
Legacy Infrastructure [Member]
Infrastructure Business
Net Sales by segments		5,091	2,193
Plant and Cannabinoid [Member]
Infrastructure Business
Net Sales by segments		25
Rental Income [Member] | Legacy Infrastructure [Member]
Infrastructure Business
Net Sales by segments	[1]	30	45
Construction Contracts [Member] | Legacy Infrastructure [Member]
Infrastructure Business
Net Sales by segments	[2]	0	62
Purchase and Resale of Physical Commodities [Member] | Legacy Infrastructure [Member]
Infrastructure Business
Net Sales by segments	[3]	5,061	2,086
Cannabinoid Products and Therapies [Member] | Plant and Cannabinoid [Member]
Infrastructure Business
Net Sales by segments	[4]	$ 25	$ 0
[1]	Rental income consists of income from rental of heavy construction equipment like bulldozers, excavators, rollers and pavers, among others.
[2]	Relates to the income from execution of construction contracts.
[3]	Relates to the income from purchase and resale of physical commodities used in infrastructure, like steel, marble and tiles.
[4]	Relates to the revenue from plant and cannabinoid-based products and therapies such as hemp crude extract, hemp isolate, and hemp distillate. There was no revenue from Hyalolex in Fiscal 2019.

NOTE 3 - INVENTORY (Details) -

NOTE 3 - INVENTORY (Details) - Schedule of Inventory, Current - USD ($) $ in Thousands	Mar. 31, 2019	Mar. 31, 2018
Schedule of Inventory, Current [Abstract]
WIP	$ 248	$ 486
Total	$ 248	$ 486

NOTE 4 - DEPOSITS AND ADVANCE_2

NOTE 4 - DEPOSITS AND ADVANCES (Details) - Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure - USD ($) $ in Thousands	Mar. 31, 2019	Mar. 31, 2018
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Advance to suppliers and consultants	$ 720	$ 300
Statutory advances	43	44
Other current assets	18	11
Total	$ 781	$ 355

NOTE 5 - INTANGIBLE ASSETS (Det

NOTE 5 - INTANGIBLE ASSETS (Details) - USD ($) $ in Thousands	Sep. 25, 2018	Mar. 31, 2019	Mar. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Finite-Lived Intangible Asset, Useful Life		13 years
Stock Issued During Period, Value, Purchase of Assets	$ 1,340		$ 42

NOTE 5 - INTANGIBLE ASSETS (D_2

NOTE 5 - INTANGIBLE ASSETS (Details) - Schedule of Intangible Assets And Goodwill - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
NOTE 5 - INTANGIBLE ASSETS (Details) - Schedule of Intangible Assets And Goodwill [Line Items]
Patent & Other Intangible Assets at the beginning of the period	$ 128	$ 0
Total	184	128
Patents [Member]
NOTE 5 - INTANGIBLE ASSETS (Details) - Schedule of Intangible Assets And Goodwill [Line Items]
Patent acquisition and filing expenses for 12 months (Net)	$ 56	$ 128

NOTE 6 - PROPERTY, PLANT AND _3

NOTE 6 - PROPERTY, PLANT AND EQUIPMENT (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Property, Plant and Equipment [Abstract]
Depreciation, Depletion and Amortization	$ 59	$ 19

NOTE 6 - PROPERTY, PLANT AND _4

NOTE 6 - PROPERTY, PLANT AND EQUIPMENT (Details) - Property, Plant and Equipment - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 8,357	$ 8,838
Less: Accumulated depreciation	(2,471)	(2,601)
Net Assets	$ 5,886	6,237
Land [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life
Property, plant and equipment, gross	$ 4,872	5,175
Building and Building Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	25 years
Property, plant and equipment, gross	$ 1,268	955
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	20 years
Property, plant and equipment, gross	$ 1,603	1,703
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	3 years
Property, plant and equipment, gross	$ 165	159
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	5 years
Property, plant and equipment, gross	$ 109	115
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	5 years
Property, plant and equipment, gross	$ 61	65
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	5 years
Property, plant and equipment, gross	$ 279	292
Construction in Progress [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life
Property, plant and equipment, gross	$ 0	$ 374

NOTE 7 - INVESTMENTS IN UNLIS_3

NOTE 7 - INVESTMENTS IN UNLISTED SECURITIES (Details) - USD ($) shares in Thousands, $ in Thousands	Dec. 18, 2014	Dec. 31, 2018	Mar. 31, 2019		Mar. 31, 2018		Mar. 31, 2017
NOTE 7 - INVESTMENTS IN UNLISTED SECURITIES (Details) [Line Items]
Investment, Percentage Sold		1.34%
Consideration for Sale of Investments		$ 5
Cost Method Investments			$ 794		$ 799
Middle Town Partners Co [Member]
NOTE 7 - INVESTMENTS IN UNLISTED SECURITIES (Details) [Line Items]
Stock Issued During Period, Shares, Acquisitions (in Shares)	1,200
Stock Issued During Period, Value, Acquisitions	$ 888
Cost Method Investment, Ownership Percentage	24.90%
Cost Method Investments			$ 773	[1]	$ 773	[1]	$ 773
[1]	Pursuant to the December 18, 2014 Purchase Agreement with Apogee, we issued Apogee 1,200 thousand shares of IGC's common stock valued at $888 thousand for the purchase of a 24.9% ownership interest in Midtown Partners & Co., LLC (MTP). During Fiscal 2018, after considering several factors, the Company concluded that it no longer had significant influence over MTP. Hence, we did not record any impact of MTP's earnings/(losses) and instead we maintained the same value as of March 31, 2017 or (approximately $773 thousand).

NOTE 7 - INVESTMENTS IN UNLIS_4

NOTE 7 - INVESTMENTS IN UNLISTED SECURITIES (Details) - Schedule of Investments - USD ($) $ in Thousands		Mar. 31, 2019		Mar. 31, 2018		Mar. 31, 2017
NOTE 7 - INVESTMENTS IN UNLISTED SECURITIES (Details) - Schedule of Investments [Line Items]
Investment		$ 794		$ 799
Investment in Equity Shares of Unlisted Company Associates [Member]
NOTE 7 - INVESTMENTS IN UNLISTED SECURITIES (Details) - Schedule of Investments [Line Items]
Investment	[1]	21		26
Middle Town Partners Co [Member]
NOTE 7 - INVESTMENTS IN UNLISTED SECURITIES (Details) - Schedule of Investments [Line Items]
Investment		$ 773	[2]	$ 773	[2]	$ 773
[1]	The movement between the two reporting periods is based on the sale at cost of 1.34% of the investment in the amount of $5 thousand to a director of our subsidiary and fluctuations in the exchange rate. The investment is recorded at cost.
[2]	Pursuant to the December 18, 2014 Purchase Agreement with Apogee, we issued Apogee 1,200 thousand shares of IGC's common stock valued at $888 thousand for the purchase of a 24.9% ownership interest in Midtown Partners & Co., LLC (MTP). During Fiscal 2018, after considering several factors, the Company concluded that it no longer had significant influence over MTP. Hence, we did not record any impact of MTP's earnings/(losses) and instead we maintained the same value as of March 31, 2017 or (approximately $773 thousand).

NOTE 8 - CLAIMS AND ADVANCES (D

NOTE 8 - CLAIMS AND ADVANCES (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
NOTE 8 - CLAIMS AND ADVANCES (Details) [Line Items]
Payments to Acquire Notes Receivable	$ 200
Debt Instrument, Interest Rate During Period	3.00%
Payments to Acquire Property, Plant, and Equipment	$ 15	$ 136
Deposit Assets	354
Land [Member]
NOTE 8 - CLAIMS AND ADVANCES (Details) [Line Items]
Payments to Acquire Property, Plant, and Equipment	$ 578

NOTE 8 - CLAIMS AND ADVANCES _2

NOTE 8 - CLAIMS AND ADVANCES (Details) - Schedule of Other Assets, Noncurrent - USD ($) $ in Thousands		Mar. 31, 2019	Mar. 31, 2018
Schedule of Other Assets, Noncurrent [Abstract]
Claims receivable	[1]	$ 404	$ 0
Non-current deposits		18	18
Other advances	[2]	456	466
Total		$ 878	$ 484
[1]	The claims receivables are due from the Cochin International Airport. Cochin International Airport is partially owned by the State Government of Kerala. The receivables have been due for periods in excess of one year as of March 31, 2019. The Company continues to carry the full value of the receivables without interest and without any impairment, because it believes that there is minimal risk that this organization will become insolvent and unable to make payment. From the Company's past experience, Company believes it will be difficult to receive the amount in next 12 months due to time taken by legal proceedings and the option to appeal in higher jurisdiction.
[2]	Includes a loan of $200 thousand, to one of our manufacturers, for the purchase of equipment, at an annual interest rate of three percent (3%), due on April 1, 2021. On May 21, 2012, TBL entered into an agreement with Weave & Weave for the purchase of land valued at approximately $578 thousand. TBL gave Weave and Weave an advance of approximately $354 thousand. We believe the amount is unrecoverable and hence a provision has been created in Fiscal 2019.

NOTE 9 - ACCRUED LIABILITIES _3

NOTE 9 - ACCRUED LIABILITIES AND OTHERS (Details) - Schedule of Accounts Payable and Accrued Liabilities - USD ($) $ in Thousands	Mar. 31, 2019	Mar. 31, 2018
Schedule of Accounts Payable and Accrued Liabilities [Abstract]
Statutory payables	$ 4	$ 4
Salaries and other contribution	115	199
Provision for expenses	355	56
Other current liability	35	29
Total	$ 509	$ 288

NOTE 10 - LOANS AND OTHER LIA_3

NOTE 10 - LOANS AND OTHER LIABILITIES (Details) - Loans Payable [Member] - Note Payable 1 [Member] - USD ($) $ in Thousands	Dec. 10, 2010	Mar. 31, 2019	Dec. 27, 2018	Oct. 16, 2009
NOTE 10 - LOANS AND OTHER LIABILITIES (Details) [Line Items]
Debt Instrument, Face Amount				$ 2,000
Repayments of Notes Payable	$ 200
Notes Payable	$ 1,800		$ 1,500
Stock Issued During Period, Shares, Other (in Shares)		30,000
Stock Issued During Period, Value, Other		$ 18
Gain (Loss) on Extinguishment of Debt		$ 300

NOTE 10 - LOANS AND OTHER LIA_4

NOTE 10 - LOANS AND OTHER LIABILITIES (Details) - Schedule of Loans and Other Liabilities - USD ($) $ in Thousands	Mar. 31, 2019	Mar. 31, 2018
Schedule of Loans and Other Liabilities [Abstract]
Statutory reserve	$ 15	$ 15
Total	$ 15	$ 15

NOTE 11 - COMMITMENTS AND CON_2

NOTE 11 - COMMITMENTS AND CONTINGENCY (Details)	12 Months Ended
	Mar. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
Defined Contribution Plan, Employer Matching Contribution, Percent of Match	6.00%
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay	12.00%

NOTE 12 - SECURITIES (Details)

NOTE 12 - SECURITIES (Details) - USD ($) $ / shares in Units, $ in Thousands	Mar. 23, 2019	Oct. 31, 2018	Dec. 31, 2018	Mar. 31, 2019	Mar. 31, 2018
Stockholders' Equity Note [Abstract]
Common Stock, Shares Authorized				150,000,000	150,000,000
Common Stock, Par or Stated Value Per Share (in Dollars per share)				$ 0.0001	$ 0.0001
Units Outstanding				91,472
Units Issued				91,472
Common Stock, Shares, Issued				39,501,407	30,764,192
Common Stock, Shares, Outstanding				39,501,407	30,764,192
Class of Warrant or Right, Outstanding				11,672,178
Class of Warrant or Right, Number of Securities Called by Warrants or Rights				1,167,217
Warrant Description of Call Feature				10 warrants and a payment of $5.00 in exchange for each share of common stock
Unit Call Feature				Ten units may be separated into one share of common stock and 20 warrants
Stock Issued During Period, Shares, New Issues		869,565		5,898,656
Proceeds from Other Equity (in Dollars)				$ 28,500
Stock Issued During Period, Value, New Issues (in Dollars)		$ 1,000		$ 28,508	$ 3,489
Stock Issued During Period, Shares, Issued for Services				107,133
Stock Issued During Period, Value, Issued for Services (in Dollars)				$ 52
Stock Repurchased and Retired During Period, Shares	80,000
Stockholders' Equity, Other Shares			80,000
Stock Issued During Period, Value, Stock Options Exercised (in Dollars)				$ 178
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period				490,000	0

NOTE 13- RELATED PARTY TRANSA_2

NOTE 13- RELATED PARTY TRANSACTIONS (Details) - USD ($)	12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
NOTE 13- RELATED PARTY TRANSACTIONS (Details) [Line Items]
Interest Expense, Related Party	$ 14,000	$ 31,000
Loans Payable [Member]
NOTE 13- RELATED PARTY TRANSACTIONS (Details) [Line Items]
Notes Payable, Related Parties	$ 50,000
Debt Instrument, Interest Rate, Stated Percentage	15.00%
Repayments of Related Party Debt	$ 377,000
Monthly Payment for Office Space and Certain General and Administrative Services [Member] | Affiliated Entity [Member]
NOTE 13- RELATED PARTY TRANSACTIONS (Details) [Line Items]
Related Party Transaction, Amounts of Transaction	4,500
Operating Leases, Rent Expense	54,000	$ 73,000
Monthly Payment for Office and Facilities [Member] | Affiliated Entity [Member]
NOTE 13- RELATED PARTY TRANSACTIONS (Details) [Line Items]
Related Party Transaction, Amounts of Transaction	$ 6,100

NOTE 14 - STOCK-BASED COMPENS_3

NOTE 14 - STOCK-BASED COMPENSATION (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Mar. 31, 2017
NOTE 14 - STOCK-BASED COMPENSATION (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	270,000	650,000	160,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	110,000	490,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized (in Dollars)	$ 667
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options (in Dollars)	$ 101
2008 Omnibus Incentive Plan and 2018 Omnibus Incentive Plan [Member]
NOTE 14 - STOCK-BASED COMPENSATION (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	2,100,000
2018 Omnibus Incentive Plan [Member]
NOTE 14 - STOCK-BASED COMPENSATION (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	6,372,127

NOTE 14 - STOCK-BASED COMPENS_4

NOTE 14 - STOCK-BASED COMPENSATION (Details) - Fair Value Measurement Inputs and Valuation Techniques	12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Fair Value Measurement Inputs and Valuation Techniques [Abstract]
Expected life of options	5 years	7 years
Vested options	100.00%	100.00%
Risk free interest rate	0.70%	0.70%
Expected volatility	119.50%	119.50%
Expected dividend yield

NOTE 14 - STOCK-BASED COMPENS_5

NOTE 14 - STOCK-BASED COMPENSATION (Details) - Disclosure of Share-based Compensation Arrangements by Share-based Payment Award - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	$ 515	$ 260
Option-based Compensation to Advisers and Contractors [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	59	93
Cost of Sales [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	0	41
Cost of Sales [Member] | Option-based Compensation to Advisers and Contractors [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	0	29
Selling, General and Administrative Expenses [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	515	219
Selling, General and Administrative Expenses [Member] | Option-based Compensation to Advisers and Contractors [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	48	43
Finite-Lived Intangible Assets [Member] | Option-based Compensation to Advisers and Contractors [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation	$ 11	$ 21

NOTE 14 - STOCK-BASED COMPENS_6

NOTE 14 - STOCK-BASED COMPENSATION (Details) - Share-based Compensation, Stock Options, Activity - shares	12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Share-based Compensation, Stock Options, Activity [Abstract]
Opening balance	650,000	160,000
Option Granted during the period	110,000	490,000
Option Exercise during the period	(490,000)	0
Closing balance	270,000	650,000

NOTE 15 - EMPLOYEE BENEFITS (De

NOTE 15 - EMPLOYEE BENEFITS (Details)	12 Months Ended
	Mar. 31, 2019
Retirement Benefits [Abstract]
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay	12.00%

NOTE 15 - EMPLOYEE BENEFITS (_2

NOTE 15 - EMPLOYEE BENEFITS (Details) - Schedule of Changes in Accumulated Postemployment Benefit Obligations - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Schedule of Changes in Accumulated Postemployment Benefit Obligations [Abstract]
Projected Benefit Obligation (PBO) at the beginning of the year	$ 15	$ 12
Service cost	1	1
interest cost	1	1
Benefits paid	0	0
Actuarial (gain)/loss	(1)	1
PBO at the end of the year	16	15
Funded status	$ 15	$ 14

NOTE 15 - EMPLOYEE BENEFITS (_3

NOTE 15 - EMPLOYEE BENEFITS (Details) - Schedule of Net Benefit Costs - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Schedule of Net Benefit Costs [Abstract]
Service cost	$ 1	$ 1
Interest cost	1	1
Expected return on plan assets	(1)	(1)
Actuarial (gain)/loss	(1)	1
Net gratuity cost	$ 0	$ 1

NOTE 15 - EMPLOYEE BENEFITS (_4

NOTE 15 - EMPLOYEE BENEFITS (Details) - Schedule of Assumptions Used	12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Schedule of Assumptions Used [Abstract]
Discount rate	7.50%	7.50%
Rate of increase in compensation levels	7.00%	7.00%

NOTE 15 - EMPLOYEE BENEFITS (_5

NOTE 15 - EMPLOYEE BENEFITS (Details) - Schedule of Expected Benefit Payments - USD ($)	Mar. 31, 2019	Mar. 31, 2018
Schedule of Expected Benefit Payments [Abstract]
Expected contribution during the year ending Year 1	$ 5,000	$ 5,000
Year 2	2,000	2,000
Year 3	500	500
Year 4	4,000	4,000
Year 5	300	300
Thereafter	$ 6,000	$ 6,000

NOTE 16 - INCOME TAXES (Details

NOTE 16 - INCOME TAXES (Details)	12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Income Tax Disclosure [Abstract]
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	21.00%	35.00%

NOTE 16 - INCOME TAXES (Detai_2

NOTE 16 - INCOME TAXES (Details) - Schedule of Components of Income Tax Expense (Benefit) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Current:
Federal	$ 0	$ 0
Foreign	2	1
State	0	0
Net Current	2	1
Deferred:
Federal	0	0
Foreign	0	0
State	0	0
Total tax provision	$ 2	$ 1

NOTE 16 - INCOME TAXES (Detai_3

NOTE 16 - INCOME TAXES (Details) - Schedule of Components of Income Tax Expense (Benefit) - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Schedule of Components of Income Tax Expense (Benefit) [Abstract]
Deferred tax expense/(benefit)	$ 0	$ 0
Net operating loss carry forward	758	577
Foreign Tax Credits	0	0
Less: Valuation Allowance	758	577
Net deferred tax expense	$ 0	$ 0

NOTE 16 - INCOME TAXES (Detai_4

NOTE 16 - INCOME TAXES (Details) - Schedule of Effective Income Tax Rate Reconciliation - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Schedule of Effective Income Tax Rate Reconciliation [Abstract]
Computed expected income tax expense/(benefit)	$ 758	$ 577
State tax benefit net of federal tax	0	0
Change in valuation allowance	758	577
Deferred expenses from foreign acquisition	0	0
Impairment loss on goodwill	0	0
Impairment loss on investments	0	0
Capitalized interest costs	0	0
Deferred tax assets from foreign subsidiaries	0	0
Other	$ 0	$ 0
Effective income tax rate	0.00%	0.00%

NOTE 17 - SEGMENT INFORMATION_2

NOTE 17 - SEGMENT INFORMATION (Details)	12 Months Ended
	Mar. 31, 2019
Segment Reporting [Abstract]
Number of Operating Segments	2
Number of Reportable Segments	2

NOTE 17 - SEGMENT INFORMATION_3

NOTE 17 - SEGMENT INFORMATION (Details) - Revenue from External Customers by Products and Services - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Revenue from External Customer [Line Items]
Revenue	$ 5,116	$ 2,193
Percentage of Total Revenue	100.00%	100.00%
Legacy Infrastructure [Member]
Revenue from External Customer [Line Items]
Revenue	$ 5,091	$ 2,193
Percentage of Total Revenue	99.00%	100.00%
Plant and Cannabinoid [Member]
Revenue from External Customer [Line Items]
Revenue	$ 25	$ 0
Percentage of Total Revenue	1.00%	0.00%

NOTE 17 - SEGMENT INFORMATION_4

NOTE 17 - SEGMENT INFORMATION (Details) - Revenue from External Customers by Geographic Areas - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
NOTE 17 - SEGMENT INFORMATION (Details) - Revenue from External Customers by Geographic Areas [Line Items]
Revenue	$ 5,116	$ 2,193
Percentage of Total Revenue	100.00%	100.00%
INDIA | Asia [Member]
NOTE 17 - SEGMENT INFORMATION (Details) - Revenue from External Customers by Geographic Areas [Line Items]
Revenue	$ 70	$ 396
Percentage of Total Revenue	1.00%	18.00%
HONG KONG | Asia [Member]
NOTE 17 - SEGMENT INFORMATION (Details) - Revenue from External Customers by Geographic Areas [Line Items]
Revenue	$ 5,021	$ 1,797
Percentage of Total Revenue	98.00%	82.00%
North America [Member]
NOTE 17 - SEGMENT INFORMATION (Details) - Revenue from External Customers by Geographic Areas [Line Items]
Revenue	$ 25	$ 0
Percentage of Total Revenue	1.00%	0.00%

NOTE 17 - SEGMENT INFORMATION_5

NOTE 17 - SEGMENT INFORMATION (Details) - Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas - USD ($) $ in Thousands	Mar. 31, 2019	Mar. 31, 2018	Mar. 31, 2017
Revenues from External Customers and Long-Lived Assets [Line Items]
Intangible assets, net	$ 184	$ 128	$ 0
Property, plant and equipment, net	5,886	6,237
Investments in unlisted securities	794	799
Claims and advances	878	484
Total long-term assets	7,742	7,648
Geographic Distribution, Domestic [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Intangible assets, net	184	128
Property, plant and equipment, net	958	1,001
Investments in unlisted securities	773	773
Claims and advances	440	0
Total long-term assets	2,355	1,902
Geographic Distribution, Foreign [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Intangible assets, net	0	0
Property, plant and equipment, net	4,928	5,236
Investments in unlisted securities	21	26
Claims and advances	438	484
Total long-term assets	$ 5,387	$ 5,746

NOTE 18 - SUBSEQUENT EVENTS (De

NOTE 18 - SUBSEQUENT EVENTS (Details)	Mar. 31, 2020a
Subsequent Event [Member]
NOTE 18 - SUBSEQUENT EVENTS (Details) [Line Items]
Area of Land	100